![Matthew Angel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Angel
Chief Executive Officer at
TEMPEST THERAPEUTICS, INC.
Net worth: 6 M $ as of 2026-08-30
Profile
Matthew Angel was the founder of Novellus LLC, founded in 2014, serving as Chief Science Officer from 2014 to 2021.
Dr. Angel is the founder of Exacis Biotherapeutics, Inc., founded in 2020, serving as Director & Chief Scientific Officer since 2020.
Dr. Angel is the founder of Factor Bioscience, Inc., founded in 2011, serving as Chairman & Chief Executive Officer since 2011.
Dr. Angel is President, Chief Executive Officer & Director at Tempest Therapeutics, Inc. since 2026.
Former positions include President & Chief Executive Officer at Ernexa Therapeutics, Inc. in 2023.
Education includes a doctorate from Massachusetts Institute of Technology and an undergraduate degree from Princeton University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-05-27 | 5,068,552 ( 37.6% ) | 6 M $ | 2026-08-30 |
Matthew Angel active positions
| Companies | Position | Start |
|---|---|---|
| TEMPEST THERAPEUTICS, INC. | Chief Executive Officer | 2026-02-02 |
Factor Bioscience, Inc.
 Factor Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Develops regenerative medicine by targeting and repairing the molecular origins of disease | Chief Executive Officer | 2010-12-31 |
Exacis Biotherapeutics, Inc.
 Exacis Biotherapeutics, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Founder | 2019-12-31 |
Former positions of Matthew Angel
| Companies | Position | End |
|---|---|---|
| ERNEXA THERAPEUTICS INC. | Chief Executive Officer | 2023-12-30 |
| ERNEXA THERAPEUTICS INC. | Chief Executive Officer | 2023-08-03 |
Novellus LLC
 Novellus LLC Pharmaceuticals: MajorHealth Technology Operates a pre-clinical stage biotechnology company that develops engineered cellular medicines | Founder | 2021-06-30 |
Training of Matthew Angel
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
18
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novellus LLC
Novellus LLC Pharmaceuticals: MajorHealth Technology Operates a pre-clinical stage biotechnology company that develops engineered cellular medicines | Health Technology |
Factor Bioscience, Inc.
Factor Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Develops regenerative medicine by targeting and repairing the molecular origins of disease | Commercial Services |
Exacis Biotherapeutics, Inc.
Exacis Biotherapeutics, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Health Services |
Eterna Therapeutics, Inc.
 Eterna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops cytokine-based drugs for the treatment of cancer | Health Technology |
Tempest Therapeutics, Inc.
 Tempest Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology pharmaceuticals | Health Technology |
- Stock Market
- Insiders
- Matthew Angel
